Paramore Miriam J
SEC CIK 1713156 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OPRX | OptimizeRx Corp | Pres, Chief STRATEGY Off | 71.0K | — | $5.65M | 13 | 2021-07-02 | 2021-12-02 |
Most active insiders at OPRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Silvestro Stephen L | CEO | — | $30.4K |
| 2 | Stelmakh Edward | Chief Fin, Strat Off | — | $18.8K |
| 3 | Presti Mariyamma Varghese | Dir | — | — |
| 4 | Merrell Brendan W. | COO | — | — |
| 5 | D'Silva Andrew J. | Chief Business Off | — | — |
| 6 | Greco Theresa | Chief Commercial Off | — | — |
| 7 | Besch Doug | Chief Product, Tech Off | — | — |
| 8 | Odence-Ford Marion | Chief Legal, Admin Off | — | — |
| 9 | Lang James Paul | Dir | — | — |
| 10 | Vos Ellen O'Connor | Dir | — | — |
Paramore Miriam J made no open-market trades at OPRX in the last 12 months.
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-03 | 2021-12-02 | OPRX | OptimizeRx Corp | Paramore Miriam J | Pres AND CSO | S - Sale+OE | $61.48 | -3,558 | 71.0K | -5% | -$218.7K |
| D | 2021-12-03 | 2021-12-02 | OPRX | OptimizeRx Corp | Paramore Miriam J | Pres AND CSO | M - OptEx | $7.51 | +3,558 | 74.6K | +5% | +$26.7K |
| D | 2021-11-03 | 2021-11-02 | OPRX | OptimizeRx Corp | Paramore Miriam J | Pres, Chief STRATEGY Off | M - OptEx | $7.51 | +15.0K | 89.6K | +20% | +$112.7K |
| D | 2021-11-03 | 2021-11-02 | OPRX | OptimizeRx Corp | Paramore Miriam J | Pres, Chief STRATEGY Off | S - Sale+OE | $95.45 | -15.0K | 74.6K | -17% | -$1.43M |
| D | 2021-10-05 | 2021-10-04 | OPRX | OptimizeRx Corp | Paramore Miriam J | Pres AND CSO | S - Sale+OE | $84.67 | -15.0K | 74.6K | -17% | -$1.27M |
| D | 2021-10-05 | 2021-10-04 | OPRX | OptimizeRx Corp | Paramore Miriam J | Pres AND CSO | M - OptEx | $7.51 | +15.0K | 89.6K | +20% | +$112.7K |
| D | 2021-09-03 | 2021-09-02 | OPRX | OptimizeRx Corp | Paramore Miriam J | Pres AND CSO | S - Sale+OE | $68.39 | -15.0K | 74.6K | -17% | -$1.03M |
| D | 2021-09-03 | 2021-09-02 | OPRX | OptimizeRx Corp | Paramore Miriam J | Pres AND CSO | M - OptEx | $7.51 | +15.0K | 89.6K | +20% | +$112.7K |
| D | 2021-08-03 | 2021-08-02 | OPRX | OptimizeRx Corp | Paramore Miriam J | Pres AND CSO | M - OptEx | $7.51 | +15.0K | 89.6K | +20% | +$112.7K |
| D | 2021-08-03 | 2021-08-02 | OPRX | OptimizeRx Corp | Paramore Miriam J | Pres AND CSO | S - Sale+OE | $55.76 | -15.0K | 74.6K | -17% | -$836.4K |
| D | 2021-07-19 | 2021-07-15 | OPRX | OptimizeRx Corp | Paramore Miriam J | Pres | M - OptEx | $3.15 | -67.2K | 74.6K | -47% | -$211.7K |
| D | 2021-07-02 | 2021-07-02 | OPRX | OptimizeRx Corp | Paramore Miriam J | Pres AND CSO | M - OptEx | $3.15 | +15.0K | 22.4K | +202% | +$47.2K |
| D | 2021-07-02 | 2021-07-02 | OPRX | OptimizeRx Corp | Paramore Miriam J | Pres AND CSO | S - Sale+OE | $57.81 | -15.0K | 7,412 | -67% | -$867.1K |
Purchase Sale Sale after option exercise All abbreviations